The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Bupivacaine 5 mg/ml Solution for Injection

Baxter Holding B.V.PA2299/035/002

Main Information

Trade NameBupivacaine 5 mg/ml Solution for Injection
Active SubstancesBupivacaine hydrochloride, monohydrate
Dosage FormSolution for injection
Licence HolderBaxter Holding B.V.
Licence NumberPA2299/035/002

Group Information

ATC CodeN01BB Amides
N01BB10 levobupivacaine


License statusAuthorised
Licence Issued03/09/2010
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back